1.Comparison between IQQA liver image analysis system and manu-traced approaches on liver volume estimation in living donor liver transplantation
Lin WEI ; Wen-tao NG JIA ; Wei GAO ; Tao YANG ; Zhi-gui ZENG ; Hao WANG ; Zhong-yang SHEN ; Zhi-jun ZHU
Chinese Journal of Organ Transplantation 2012;33(6):351-353
Objective To investigate the safty and accuracy ot estimating the living donor's graft volume with IQQA liver imaging evaluation system.Methods Between June 2007 and July 2010,123living liver donors were enrolled to undergo 16-slice CT scanning,then graft volume was estimated by both IQQA and manu-traced multi-slice spiral computed tomography (MSCT) approach.The graft volume and time consuming between IQQA and manu-traced MSCT were compared. Pearson Correlation test was uesd to verify the correlation between the estimated graft volume estimated each method and actual graft weight detected in operation.Linear correlation analysis was done.Results The mean graft volume by IQQA and manu-traced MSCT was (856.76 ± 162.18) and (870.64 ±172.54) cm3 respectively preoperation.Paired t-test showed there was no statistically significant difference between IQQA and MSCT methods (P>0.05).It took mean ( 16.9 ± 1.4) min to calculatethe graft volume by IQQA and (39.3 ± 2.1 ) min by manu-traced MSCT,respectively (P<0.05).The real graft volume was (632.59 ± 13 1.73) cm3.Pearson correlation test showed the graft volume calculated by either IQQA or MSCT method had a significantly positive correlation with the real graft weight (MSCT r =0.921,IQQA r =0.896,P<0.01 ).Graft weight could be expressed in the equation:Actual graft weight =- 150.303 + 1.025 × IQQA value or =- 94.397 + 0.955 × MSCT value.Conclusion IQQA system has same accuracy with MSCT method in predicting the graft volume but consuming less time.IQQA system promotes the recognition of clinician on liver three dimensional anatomic structure.
3.Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
Zhe Min WANG ; Jia Hao LAW ; Nicolas Kon Kam KING ; Deshan Kumar RAJESWARAN ; Samantha SOH ; Jai Prashanth RAO ; Wai Hoe NG ; Karen Sui Geok CHUA
Singapore medical journal 2016;57(1):8-12
INTRODUCTIONIntrathecal baclofen (ITB) therapy is a proven, effective treatment for disabling cortical spasticity. We describe the first local series of five patients with acquired brain injury (ABI) who received ITB and were followed up for 63.8 months.
METHODSA retrospective review of medical and rehabilitation records of patients who received ITB therapy was carried out. Data studied included baseline demographic and injury variables, implantation data, spasticity and function, ITB dosage over time and complications.
RESULTSFrom 2006 to 2010, a total of five patients received ITB therapy via implanted pumps about 39.4 months after ABI. Four out of five patients experienced significant reductions in their lower limb spasticity scores and improvements in global function and dependency. One patient had minor adverse events associated with baclofen-related sedation. The mean ITB dose at one year was 182.7 ± 65.6 mcg/day.
CONCLUSIONOur preliminary study showed encouraging long-term outcomes and safety for ITB therapy after ABI-related intractable spasticity. Individual ITB responses over time were variable, with gender differences. The outcomes experienced by our centre were comparable to those in the general ABI population, supporting the efficacy of ITB therapy for chronic disabling spasticity.
Baclofen ; administration & dosage ; Brain Injuries ; complications ; drug therapy ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Humans ; Infusion Pumps, Implantable ; Injections, Spinal ; Male ; Muscle Relaxants, Central ; administration & dosage ; Muscle Spasticity ; diagnosis ; drug therapy ; etiology ; Retrospective Studies ; Severity of Illness Index ; Singapore ; epidemiology ; Tertiary Care Centers ; Treatment Outcome
4. Chemical constituents and pharmacological effects of durian shells in ASEAN countries: A review
Yuan-fei ZHAN ; Xiao-tao HOU ; Li-li FAN ; Yuan-fei ZHAN ; Xiao-tao HOU ; Li-li FAN ; Zheng-cai DU ; Er-wei HAO ; Jia-gang DENG ; Yuan-fei ZHAN ; Xiao-tao HOU ; Li-li FAN ; Zheng-cai DU ; Er-wei HAO ; Jia-gang DENG ; Yuan-fei ZHAN ; Xiao-tao HOU ; Zheng-cai DU ; Soo Ee CH'NG ; Khamphanh THEPKAYSONE ; Er-wei HAO ; Jia-gang DENG ; Xiao-tao HOU ; Zheng-cai DU ; Er-wei HAO ; Jia-gang DENG ; Soo Ee CH'NG ; Siok Meng NG ; Khamphanh THEPKAYSONE
Chinese Herbal Medicines 2021;13(4):461-471
Durio zibethnus is mainly distributed in Southeast Asia. Traditional Chinese medicine believes that durian shells have the effects of clearing heat and purging fire, nourishing yin and moisturizing dryness. Therefore, it is often used as a pharmaceutic food in the Chinese folk to assist treating diseases. At present, the chemical constituents isolated from durian shell include phenolic acids, phenolic glycosides, flavonoids, coumarins, triterpenes, simple glycosides and other compounds. Modern pharmacological studies show that durian shell has many pharmacological activities, such as antioxidant, anti-inflammatory, regulation of glucose and lipid metabolism. The chemical composition and pharmacological effects of durian shells are summarized in order to provide references for the further research and application of durian shell.